The antisera market in Canada is poised for steady growth, with forecasted values reaching $11.136 billion in 2024 and gradually increasing to $11.899 billion by 2028. This illustrates a consistent upward trend. Between 2024 and 2028, the Compounded Annual Growth Rate (CAGR) reflects a stable year-on-year increase, highlighting a healthy expansion within the market over the 5-year forecast period.

Future trends to watch for include:

Rising demand for immunotherapy and advancements in biotechnology, which are likely to drive further growth.
Potential regulatory changes in Canada that may impact the production and distribution of antisera.
Increased investment in research and development that can enhance the quality and range of antisera products available in the market.
Growing public health initiatives that may boost the need for antisera solutions.